Glengarry Private Hospital
Part of Ramsay Health Care

Glengarry Private Hospital specialist Andrew Dean

A/Professor Andrew Dean

MBChB MRCP FRACP

Andrew’s key areas of interest are upper gastrointestinal and gynaecological tumours. He has published articles on symptom control, novel therapies for ovarian cancer, pancreatic cancer and the molecular profiling of solid tumours. He regularly participates in international clinical trials and continues to be a major contributor to pancreatic, lung and ovarian cancer studies. Andrew is now leading the establishment of a fast-response medical oncology unit at Glengarry Private Hospital to further facilitate treatment close to home for patients in Perth's northern suburbs.

In 2001, having recognised a gap in health care information, Andrew established a quality health information website, as a resource for patients, their families and allied health professionals. Together with a host of IT initiative awards, his efforts were recognised by the 2004 Prime Minister’s Award for excellence in community business partnerships for Western Australia. Through this website, Andrew was able to sponsor a scholarship for two medical students to attend a cancer elective in Lund (Sweden) for a number of years.

Andrew is currently the head of the Department of Medical Oncology at St John of God Subiaco Hospital and, at Genesis CancerCare at Shenton House in Joondalup, where he provides patients in Perth’s northern suburbs access to care closer to home. To increase this much-needed access for a growing population, Andrew is now leading the establishment of a fast-response medical oncology unit at Glengarry Private Hospital in Duncraig.

While providing treatment across all adult solid tumours, Andrew’s key areas of interest are upper gastrointestinal and gynaecological tumours. He has published articles on symptom control, novel therapies for ovarian cancer, pancreatic cancer and the molecular profiling of solid tumours. He regularly participates in international clinical trials and continues to be a major contributor to pancreatic, lung and ovarian cancer studies.

Upper Gastrointestinal Cancer
Gynaecological Cancer
Lung Cancer
Palliative Care
French, Chinese